Clinical Rigour
Every decision we make prioritises patient safety and diagnostic accuracy. We never compromise on clinical validation.
Founded by genomic data engineers who helped build the UK’s national genomic medicine infrastructure. Now building the platform to bring precision medicine to the world.
Genomatis was founded by a team whose work has been shaped by some of the most ambitious genomic medicine and population-health programmes in the world — including the UK's contribution to the sequencing and clinical interpretation of more than 100,000 genomes for rare disease and cancer patients. The platform inherits that rigor, scale and regulatory discipline.
New professionals have joined Genomatis, bringing complementary expertise in public health, data engineering, and artificial intelligence. That collective experience revealed a critical gap: while large-scale genomic medicine had been proven viable, the technology remained inaccessible to most of the world — locked behind prohibitive costs, slow turnaround times, and fragmented infrastructure.
Genomatis exists to close that gap. We acquired deep expertise in public and private healthcare systems and in genomic data engineering and rebuilt the platform from the ground up — leveraging modern AI, cloud-native architecture, and scalable design to deliver clinical-grade genomic analysis at a single-digit percentage fraction of legacy costs for the analysis reports.
Today, our platform is enabled to process public health and genomic data for hospitals, laboratories, government health programmes, and municipalities — bringing precision medicine to populations that have never had access to it before.
To make clinical-grade genomic medicine accessible to every healthcare system in the world — regardless of size, budget, or geography.
Every decision we make prioritises patient safety and diagnostic accuracy. We never compromise on clinical validation.
Genomic medicine should not be a privilege of wealthy nations or high-income individuals. We build for the world's public and private healthcare systems — accessible to all.
Every AI-generated insight comes with a full evidence trail. Black boxes have no place in clinical genomics.
Our architecture handles one or one million genomes. We engineer for population-scale from day one.
We hire senior people who'd rather be right than fast. Genomatis is remote-first, with hubs in Brazil and the United Kingdom. We hold an unusually high bar for clinical regulation, security and engineering rigor.
Lead variant interpretation reviews under ACMG/AMP guidelines; partner with engineering on classification rules.
Own pipeline ETL, audit-grade event sourcing, tenant isolation. You will read clinical regulation as carefully as you read code.
Design federated cohort analytics for national-scale screening programmes; deploy at SUS, NHS-equivalent and reference-lab tier.
Advance VUS reclassification, polygenic risk and explainability layers across our products. Publish where it strengthens the field.
Shape clinician-facing surfaces across 9 products. The design must survive a 14-hour ICU shift and a regulatory audit, both.
Multi-region sovereign infrastructure on K8s, Postgres, Harbor. Reproducibility is not aspirational — it is enforced.
Don't see your role? We hire ahead of need for senior clinical, regulatory and engineering work. Tell us what you'd build at a clinical-grade genomics company and we'll start a conversation.
Tell us your storyTalk to our team about pilots, integrations and clinical deployments across hospitals, biobanks and public-health programs.